loading
Schlusskurs vom Vortag:
$9.04
Offen:
$9.11
24-Stunden-Volumen:
918.07K
Relative Volume:
0.56
Marktkapitalisierung:
$827.48M
Einnahmen:
$2.98B
Nettoeinkommen (Verlust:
$-300.00M
KGV:
-2.6029
EPS:
-3.4
Netto-Cashflow:
$225.00M
1W Leistung:
-7.88%
1M Leistung:
-9.58%
6M Leistung:
-12.35%
1J Leistung:
-7.59%
1-Tages-Spanne:
Value
$8.59
$9.28
1-Wochen-Bereich:
Value
$8.59
$9.91
52-Wochen-Spanne:
Value
$3.97
$18.67

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name
Firmenname
Fortrea Holdings Inc
Name
Telefon
877-495-0816
Name
Adresse
8 MOORE DRIVE, DURHAM
Name
Mitarbeiter
14,300
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
FTRE's Discussions on Twitter

Compare FTRE vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FTRE
Fortrea Holdings Inc
8.85 845.24M 2.98B -300.00M 225.00M -3.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.98 121.46B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
743.45 78.93B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
700.42 43.87B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.47 42.07B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
283.88 31.65B 5.36B 287.73M 924.18M 2.5229

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-03-09 Hochstufung TD Cowen Hold → Buy
2026-01-08 Hochstufung Truist Hold → Buy
2026-01-06 Hochstufung Evercore ISI In-line → Outperform
2025-12-15 Hochstufung Barclays Underweight → Equal Weight
2025-12-11 Hochstufung Citigroup Neutral → Buy
2025-08-04 Hochstufung Robert W. Baird Neutral → Outperform
2025-05-02 Eingeleitet Truist Hold
2025-04-10 Herabstufung Barclays Equal Weight → Underweight
2024-12-11 Herabstufung Citigroup Buy → Neutral
2024-12-06 Herabstufung Robert W. Baird Outperform → Neutral
2024-09-25 Herabstufung Jefferies Buy → Hold
2024-08-08 Herabstufung Evercore ISI Outperform → In-line
2024-07-24 Fortgesetzt Barclays Equal Weight
2024-06-06 Eingeleitet Goldman Neutral
2024-05-29 Eingeleitet TD Cowen Hold
2024-05-28 Eingeleitet Mizuho Neutral
2024-03-22 Eingeleitet Robert W. Baird Neutral
2024-03-06 Eingeleitet Deutsche Bank Hold
2024-01-05 Eingeleitet William Blair Mkt Perform
2024-01-04 Eingeleitet Jefferies Buy
2023-12-11 Hochstufung Citigroup Neutral → Buy
2023-12-01 Hochstufung Evercore ISI In-line → Outperform
2023-11-14 Hochstufung Barclays Equal Weight → Overweight
2023-10-19 Eingeleitet Citigroup Neutral
2023-09-14 Eingeleitet Evercore ISI In-line
2023-08-16 Eingeleitet Barclays Equal Weight
2023-08-07 Eingeleitet BofA Securities Underperform
Alle ansehen

Fortrea Holdings Inc Aktie (FTRE) Neueste Nachrichten

pulisher
12:33 PM

FTREFortrea Holdings Latest Stock News & Market Updates - Stock Titan

12:33 PM
pulisher
Mar 12, 2026

How sensitive is Fortrea Holdings Inc to inflationQuarterly Trade Report & Smart Money Movement Tracker - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Mar 12, 2026
pulisher
Mar 12, 2026

Discipline and Rules-Based Execution in FTRE Response - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 11, 2026

Fortrea (NASDAQ:FTRE) CAO Robert Parks Sells 1,927 Shares - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Fortrea (NASDAQ:FTRE) CFO Sells $45,903.27 in Stock - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

WINTON GROUP Ltd Has $2.57 Million Stock Holdings in Fortrea Holdings Inc. $FTRE - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Investors to Inquire about Securities Investigation - ACCESS Newswire

Mar 11, 2026
pulisher
Mar 10, 2026

Fortrea Holdings (FTRE) grants CFO new RSU and PSU awards - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Mar 10, 2026
pulisher
Mar 10, 2026

Fortrea (NASDAQ:FTRE) Stock Price Down 7.4%What's Next? - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Fortrea Holdings Earnings Call Signals Steady Turnaround - TipRanks

Mar 09, 2026
pulisher
Mar 09, 2026

How The Fortrea (FTRE) Story Is Shifting As Analysts Split On Future Upside - Yahoo Finance

Mar 09, 2026
pulisher
Mar 09, 2026

Fortrea (NASDAQ:FTRE) Upgraded by TD Cowen to "Buy" Rating - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

TD Cowen upgrades Fortrea stock rating on improving bookings - Investing.com

Mar 09, 2026
pulisher
Mar 09, 2026

TD Cowen Upgrades Fortrea Holdings to Buy, Price Target is $15 - marketscreener.com

Mar 09, 2026
pulisher
Mar 09, 2026

TD Cowen upgrades Fortrea stock rating on improving bookings By Investing.com - Investing.com Canada

Mar 09, 2026
pulisher
Mar 09, 2026

Fortrea: Strengthening Fundamentals, Cost Efficiencies, and Resilient Demand Underpin Buy Rating - TipRanks

Mar 09, 2026
pulisher
Mar 08, 2026

Fortrea Holdings Inc. $FTRE Shares Sold by Citigroup Inc. - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

Why Fortrea Holdings Inc. stock is popular among millennialsGap Down & Real-Time Buy Zone Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 07, 2026

Vanguard Group Inc. Sells 618,758 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

Death Cross: Will Fortrea Holdings Inc outperform during market rallies2025 Trading Recap & High Accuracy Swing Trade Signals - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Fortrea (FTRE) Q4 2025 Earnings Call Transcript - AOL.com

Mar 06, 2026
pulisher
Mar 06, 2026

Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

Fortrea Backs GE Healthcare’s New PET Tracer in Completed Phase 1 Study - TipRanks

Mar 06, 2026
pulisher
Mar 05, 2026

Mizuho cuts Fortrea stock price target to $13 on lower estimates By Investing.com - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

Mizuho cuts Fortrea stock price target to $13 on lower estimates - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 05, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Mar 05, 2026
pulisher
Mar 04, 2026

Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide? - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

S P Trends: How sensitive is Fortrea Holdings Inc to inflation2025 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

FTRE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 04, 2026
pulisher
Mar 04, 2026

Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Mar 04, 2026
pulisher
Mar 02, 2026

Fortrea Holdings Inc. (FTRE) 2026 Guidance Assumes Stable FX Rates from End-2025 - Finviz

Mar 02, 2026
pulisher
Mar 01, 2026

A Look At Fortrea Holdings (FTRE) Valuation After Weak Q4 Results And Soft 2025–2026 Guidance - simplywall.st

Mar 01, 2026
pulisher
Mar 01, 2026

2026-03-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Shareholders to Inquire about Securities Investigation | NDAQ:FTRE | Press Release - Stockhouse

Mar 01, 2026
pulisher
Mar 01, 2026

Behavioral Patterns of FTRE and Institutional Flows - Stock Traders Daily

Mar 01, 2026
pulisher
Feb 28, 2026

Deep Dive Into Fortrea Holdings Stock: Analyst Perspectives (7 Ratings) - Sahm

Feb 28, 2026
pulisher
Feb 28, 2026

Fortrea Holdings Inc. (FTRE) Receives a Hold from Barclays - The Globe and Mail

Feb 28, 2026
pulisher
Feb 27, 2026

Fortrea Holdings Inc. (FTRE): Investor Outlook With A Promising 37.88% Potential Upside - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 27, 2026

Barclays Adjusts Price Target for Fortrea Holdings (FTRE) While Maintaining Rating | FTRE Stock News - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Barclays Issues Pessimistic Forecast for Fortrea (NASDAQ:FTRE) Stock Price - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Fortrea Holdings Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:FTRE) 2026-02-27 - Seeking Alpha

Feb 27, 2026
pulisher
Feb 27, 2026

Deutsche Bank Adjusts Fortrea Price Target to $14 From $16, Maintains Hold Rating - marketscreener.com

Feb 27, 2026
pulisher
Feb 27, 2026

Fortrea (NASDAQ:FTRE) Price Target Lowered to $16.00 at Robert W. Baird - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Fortrea Holdings Inc. (NASDAQ:FTRE) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026
pulisher
Feb 26, 2026

Fortrea Holdings (FTRE) Posts US$986 Million TTM Loss Reinforcing Skeptical Profitability Narratives - simplywall.st

Feb 26, 2026
pulisher
Feb 26, 2026

Fortrea (NASDAQ:FTRE) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Fortrea Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Fortrea shares slip after revenue miss overshadows quarterly results - MSN

Feb 26, 2026
pulisher
Feb 26, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Connect - ACCESS Newswire

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Fortrea Holdings Q4 2025 misses forecasts, stock dips - Investing.com

Feb 26, 2026

Finanzdaten der Fortrea Holdings Inc-Aktie (FTRE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Fortrea Holdings Inc-Aktie (FTRE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Parks Robert
Chief Accounting Officer
Mar 10 '26
Sale
9.07
1,927
17,478
22,389
Morais Mark A.
Chief Operating Officer
Mar 09 '26
Option Exercise
0.00
13,966
0
72,018
Morais Mark A.
Chief Operating Officer
Mar 10 '26
Sale
9.07
4,599
41,713
67,419
Mcconnell Jill G.
Chief Financial Officer
Mar 09 '26
Option Exercise
0.00
15,283
0
74,857
Mcconnell Jill G.
Chief Financial Officer
Mar 10 '26
Sale
9.07
5,061
45,903
69,796
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):